Citigroup
OCAT

Citigroup’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Citigroup’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,647
Closed -$132K – 8136
2015
Q4 		$132K Buy
15,647
+15,640
+223,429% +$105K ﹤0.01% 5123
2015
Q3 		$0 Sell
7
-634
-99% -$2.77K ﹤0.01% 8143
2015
Q2 		$3K Buy
641
+587
+1,087% +$3.76K ﹤0.01% 7078
2015
Q1 		$0 Buy
+54
New +$346 ﹤0.01% 7669

Citigroup's OCAT Position: Q1 2016 in Review

Citigroup sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 15,647 shares — an estimated $132K sold.

Citigroup first reported a position in OCAT in Q1 2015 and held it in 4 quarters. The position peaked at $132K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Citigroup reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 15,647 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $132K.
  • Citigroup first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 4 quarters.
  • Citigroup's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $132K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.